Predicting Oral HIV Pre‐Exposure Prophylaxis Efficacy in Cisgender Women Across Pregnancy and Postpartum
Yifan Yu, Kristina M. Brooks, Gustavo F. Doncel, Brookie M. Best et autres
0 citationsThe Journal of Clinical Pharmacology
Mark Mirochnick
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
83Publications signalées
2824Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
HIV/AIDS drug development and treatmentHIV/AIDS Research and InterventionsPregnancy and Medication ImpactHIV-related health complications and treatmentsHIV Research and Treatment
Publications récentes
Breastmilk transfer and infant exposure to atazanavir/ritonavir in breastfeeding women with HIV: results from IMPAACT 2026
Emily Anne Barr, Mauricio Pinilla, Jeremiah D. Momper, Ahizechukwu C. Eke et autres
0 citationsFrontiers in Reproductive Health
Letter Reply to “Mind the Postpartum Trough: Closing the Clofazimine Exposure Gap After Delivery in Rifampicin-Resistant Tuberculosis”
Jennifer Hughes, Kristina M. Brooks, Lee Fairlie, Brookie M. Best et autres
0 citationsThe Journal of Infectious Diseases
Hypertension in a Randomized Trial of Dolutegravir- Versus Efavirenz-Based Antiretroviral Therapy in Pregnant and Postpartum Women with HIV
Risa M. Hoffman, Sean Brummel, Mauricio Pinilla, Grace Malonga et autres
0 citationsClinical Infectious Diseases
Population Pharmacokinetics of Bictegravir During Pregnancy and Postpartum: Role of Adherence in Maintaining Therapeutic Exposure
Steven A Sun, Mina Nikanjam, Mark Mirochnick, Kathleen M. Powis et autres
1 citationThe Journal of Clinical Pharmacology
Pharmacokinetics of Oral and Extended-release Naltrexone in Pregnant and Lactating Individuals and their Infants
Nicole Iannella, Jeremiah D. Momper, Mark Mirochnick, Raymond T. Suhandynata et autres
0 citationsJournal of Addiction Medicine
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate–Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum
Rich Clark, Sopida Kiattivej, Lukkana Sitiritkawin, Dip Nus Mid et autres
1 citationCarolina Digital Repository (University of North Carolina at Chapel Hill)
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate–Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum
Risa M. Hoffman, Sean S. Brummel, Lauren Ziemba, Lameck Chinula et autres
12 citationsClinical Infectious Diseases
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study
Deborah Persaud, Yvonne J. Bryson, Bryan S Nelson, Camlin Tierney et autres
27 citationsThe Lancet HIV
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s
Marije Van Schalkwyk, Adrie Bekker, Eric Decloedt, Jiajia Wang et autres
18 citationsAntimicrobial Agents and Chemotherapy
Brief Report: Dolutegravir Plasma Protein Binding and Unbound Concentrations During Pregnancy and Postpartum
Jeremiah D. Momper, Mina Nikanjam, Brookie M. Best, Mark Mirochnick et autres
7 citationsJAIDS Journal of Acquired Immune Deficiency Syndromes
Physiologically‐based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID ‐19
Xiaomei I. Liu, André Dallmann, Kristina M. Brooks, Brookie M. Best et autres
11 citationsCPT Pharmacometrics & Systems Pharmacology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.